Back
Omnicell Vs. P3 Health Partners Industry Stock Comparison
Buy
59
OMCL
Omnicell
Last Price:
41.81
Seasonality Move:
4.27%
Sell
37
PIII
P3 Health Partners
Last Price:
0.20
Seasonality Move:
-49.43%
Buy
59
Omnicell (OMCL)
is a Buy
Is Omnicell a Buy, Sell or Hold?
- The current Omnicell [OMCL] share price is $41.82. The Score for OMCL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- OMCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
P3 Health Partners (PIII)
is a Sell
Is P3 Health Partners a Buy, Sell or Hold?
- The current P3 Health Partners [PIII] share price is $0.20. The Score for PIII is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PIII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OMCL Stock Price Chart
PIII Stock Price Chart
What is P3 Health Partners's stock price today?
-
The P3 Health Partners share price today is $0.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIII is experiencing selling pressure, which indicates risk of future bearish movement.
OMCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 39.48 | Sell |
| Chaikin Money Flow: | -156796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.93 - 49.99) | Sell |
| Bollinger Bands (100): | (32.92 - 47.38) | Buy |
PIII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 28.09 | Sell |
| Chaikin Money Flow: | -934413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.43) | Sell |
| Bollinger Bands (100): | (0.35 - 0.57) | Sell |
OMCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.03 | Sell |
| 20-day SMA: | 46.57 | Sell |
| 50-day SMA: | 44.23 | Sell |
| 200-day SMA: | 34.38 | Buy |
| 8-day EMA: | 45.29 | Sell |
| 20-day EMA: | 45.89 | Sell |
| 50-day EMA: | 44.2 | Sell |
| 200-day EMA: | 39.56 | Buy |
PIII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.33 | Sell |
| 50-day SMA: | 0.38 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.37 | Sell |
| 200-day EMA: | 0.69 | Sell |
Omnicell Earnings Growth & OMCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.12 per share.
P3 Health Partners Earnings Growth & PIII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.42 per share.
Omnicell Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
P3 Health Partners Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||